Roos, FC; Thomas, C; Hampel, C et al.
Nephron-sparing surgery versus radical nephrectomy for kidney tumors: benefits and limitationsEXPERT REVIEW OF ANTICANCER THERAPY. Bd. 11. H. 6. 2011 S. 805-808
Lüssi, F; Zipp, F
Neurodegeneration in der Multiplen Sklerose - Bedeutung für die TherapieNeuro aktuell. Bd. 7. H. 28. 2011 S. 1
Lieb, K
Neuroenhancement mit MedikamentenDuriska M, Ebner-Priemer U, Stolle M (Hrsg). Rückenwind. Was Studis gegen Stress tun können. Ettlingen: Kraft 2011
Stein, R; Filipas, D; Thüroff, JW
Neurogene Blasen- und SphinkterdysfunktionStein R, Beetz R, Thüroff JW (Hrsg). Kinderurologie in Klinik und Praxis. 3. Aufl. Stuttgart: Thieme 2011
Goebel, HH
Neuropathology of neurometabolic diseases in children with epilepsyBRAIN & DEVELOPMENT. Bd. 33. H. 9. 2011 S. 726-733
Rat, Dorothea; Schmitt, Ulrich; Tippmann, Frank et al.
Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic miceThe FASEB journal. Bd. 25. H. 9. Bethesda, Md.: FASEB 2011 S. 3208 - 3218
Zipp, F; Gold, R
Neuroprotection in the treatment of multiple sclerosisNERVENARZT. Bd. 82. H. 8. 2011 S. 973-+
Herges, K; Millward, JM; Hentschel, N et al.
Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in NeuroinflammationPLOS ONE. Bd. 6. H. 10. 2011 S. -
Botia, B; Jolivel, V; Burel, D et al.
Neuroprotective Effects of PACAP Against Ethanol-Induced Toxicity in the Developing Rat CerebellumNEUROTOXICITY RESEARCH. Bd. 19. H. 3. 2011 S. 423-434
Schermuly, I; Muller, MJ; Muller, KM et al.
Neuropsychiatric symptoms and brain structural alterations in Fabry diseaseEUROPEAN JOURNAL OF NEUROLOGY. Bd. 18. H. 2. 2011 S. 347-353